Stay updated on ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page
- Check2 days agoChange DetectedAn NIH-wide notice about website changes and terminology appears above the 403 error page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedData-sharing and transparency-related sections were removed from the study record, including the IPD sharing URL, IPD sharing plan and criteria, and related notes. The deletions also remove links and descriptions for the CSR, SAP, and the full study protocol.SummaryDifference19%

- Check37 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a new build of the site's interface. The change represents an underlying software update rather than changes to visible content or user-facing features.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page shows a new revision label of v3.6.6, replacing the previous v3.6.5. This indicates a minor site update that does not affect the study details or results.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page no longer provides a direct link to results on the sponsor's results site, and sponsor-related navigation sections are removed. This reduces sponsor attribution visibility and access to study documents and resources.SummaryDifference0.2%

Stay in the know with updates to ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in Peritoneal Dialysis Clinical Trial page.